D.E. Shaw & Co
DVAX

D.E. Shaw & Co’s Dynavax Technologies DVAX Stock Holding History

D.E. Shaw & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-75,000
Closed -$1.14M – 3771
2018
Q2 		$1.14M Buy
+75,000
New +$1.3M ﹤0.01% 2623
2016
Q3 		– Sell
-16,000
Closed -$233K – 3402
2016
Q2 		$233K Hold
16,000
– – ﹤0.01% 3136
2016
Q1 		$308K Hold
16,000
– – ﹤0.01% 3007
2015
Q4 		$387K Buy
+16,000
New +$401K ﹤0.01% 3235

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's DVAX Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 632,594 shares — an estimated $9.73M sold.

D.E. Shaw & Co first reported a position in DVAX in Q2 2013 and held it in 49 quarters. The position peaked at $48.5M in Q3 2017. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 632,594 Dynavax Technologies shares in Q1 2026, an estimated $9.73M.
  • D.E. Shaw & Co first reported a position in Dynavax Technologies in Q2 2013 and held it in 49 quarters.
  • D.E. Shaw & Co's Dynavax Technologies position peaked at $48.5M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.